{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:15:15Z","timestamp":1793254515191,"version":"4.5.0"},"reference-count":134,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1038\/s41574-025-01226-5","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T10:25:35Z","timestamp":1767867935000},"page":"242-254","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The public health burden of diabetes mellitus and thyroid disease: twin epidemics"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9047-1556","authenticated-orcid":false,"given":"Salman","family":"Razvi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"1226_CR1","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.2337\/dc23-S002","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"ElSayed, N. A. et al. Classification and diagnosis of diabetes: standards of care in diabetes \u2014 2023. Diabetes Care 46, S19\u2013S40 (2023).","journal-title":"Diabetes Care"},{"key":"1226_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun, H. et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 183, 109119 (2022).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1226_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jacc.2023.04.052","volume":"82","author":"Y Handelsman","year":"2023","unstructured":"Handelsman, Y. et al. Cardiovascular outcomes in patients with diabetes and kidney disease: JACC review topic of the week. J. Am. Coll. Cardiol. 82, 161\u2013170 (2023).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1226_CR4","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s42255-024-00986-0","volume":"6","author":"RA Sinha","year":"2024","unstructured":"Sinha, R. A. & Yen, P. M. Metabolic messengers: thyroid hormones. Nat. Metab. 6, 639\u2013650 (2024).","journal-title":"Nat. Metab."},{"key":"1226_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-022-00357-7","volume":"8","author":"L Chaker","year":"2022","unstructured":"Chaker, L. et al. Hypothyroidism. Nat. Rev. Dis. Primers 8, 30 (2022).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"1226_CR6","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1001\/jamapediatrics.2016.0486","volume":"170","author":"G Binder","year":"2016","unstructured":"Binder, G. et al. Thyroid disorders in children and adolescents: a review. JAMA Pediatr. 170, 1008\u20131019 (2016).","journal-title":"JAMA Pediatr."},{"key":"1226_CR7","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/S2213-8587(23)00005-0","volume":"11","author":"P Laurberg","year":"2023","unstructured":"Laurberg, P. et al. Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis. Lancet Diabetes Endocrinol. 11, 282\u2013298 (2023).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1226_CR8","volume":"22","author":"TF Davies","year":"2023","unstructured":"Davies, T. F. et al. Graves\u2019 disease. Autoimmune Rev. 22, 102805 (2023).","journal-title":"Autoimmune Rev."},{"key":"1226_CR9","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1056\/NEJMra1510030","volume":"375","author":"TJ Smith","year":"2016","unstructured":"Smith, T. J. & Heged\u00fcs, L. Graves\u2019 disease. N. Engl. J. Med. 375, 1552\u20131565 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1226_CR10","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.autrev.2016.02.017","volume":"15","author":"GJ Kahaly","year":"2016","unstructured":"Kahaly, G. J. & Hansen, M. P. Type 1 diabetes associated autoimmunity. Autoimmun. Rev. 15, 644\u2013648 (2016).","journal-title":"Autoimmun. Rev."},{"key":"1226_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-024-02527-y","volume":"13","author":"R Hadgu","year":"2024","unstructured":"Hadgu, R., Worede, A. & Ambachew, S. Prevalence of thyroid dysfunction and associated factors among adult type 2 diabetes mellitus patients, 2000\u20132022: a systematic review and meta-analysis. Syst. Rev. 13, 119 (2024).","journal-title":"Syst. Rev."},{"key":"1226_CR12","volume":"19","author":"N Gronich","year":"2021","unstructured":"Gronich, N. et al. Hypothyroidism is a risk factor for new-onset diabetes mellitus: a population-based cohort study. BMC Med. 19, 257 (2021).","journal-title":"BMC Med."},{"key":"1226_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02121-2","volume":"19","author":"F Rong","year":"2021","unstructured":"Rong, F. et al. Association between thyroid dysfunction and type 2 diabetes: a meta-analysis of prospective observational studies. BMC Med. 19, 257 (2021).","journal-title":"BMC Med."},{"key":"1226_CR14","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1210\/clinem\/dgac006","volume":"107","author":"OHR Due\u00f1as","year":"2025","unstructured":"Due\u00f1as, O. H. R. et al. Thyroid function and the risk of prediabetes and type 2 diabetes. J. Clin. Endocrinol. Metab. 107, 1789\u20131798 (2025).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1226_CR15","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1210\/er.2018-00163","volume":"40","author":"B Biondi","year":"2019","unstructured":"Biondi, B., Kahaly, G. J. & Robertson, R. P. Thyroid dysfunction and diabetes mellitus: two closely associated disorders. Endocr. Rev. 40, 789\u2013824 (2019).","journal-title":"Endocr. Rev."},{"key":"1226_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.34172\/hpp.2020.18","volume":"10","author":"M Mobasseri","year":"2020","unstructured":"Mobasseri, M. et al. Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Health Promot. Perspect. 10, 98\u2013115 (2020).","journal-title":"Health Promot. Perspect."},{"key":"1226_CR17","doi-asserted-by":"publisher","DOI":"10.2174\/1573399817666210503133747","volume":"17","author":"AG Abela","year":"2021","unstructured":"Abela, A. G. & Fava, S. Why is the incidence of type 1 diabetes increasing. Curr. Diabetes Rev. 17, e030521193110 (2021).","journal-title":"Curr. Diabetes Rev."},{"key":"1226_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1496155","volume":"15","author":"V Herczeg","year":"2025","unstructured":"Herczeg, V. et al. Increasing prevalence of thyroid autoimmunity in childhood type 1 diabetes in the pre-COVID but not during the COVID era. Front. Endocrinol. 15, 1496155 (2025).","journal-title":"Front. Endocrinol."},{"key":"1226_CR19","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jdiacomp.2015.12.027","volume":"30","author":"C Nederstigt","year":"2016","unstructured":"Nederstigt, C., Corssmit, E. P. M., de Koning, E. J. P. & Dekkers, O. M. Incidence and prevalence of thyroid dysfunction in type 1 diabetes. J. Diabetes Complications 30, 420\u2013425 (2016).","journal-title":"J. Diabetes Complications"},{"key":"1226_CR20","doi-asserted-by":"publisher","first-page":"527","DOI":"10.4239\/wjd.v11.i11.527","volume":"11","author":"L Frommer","year":"2020","unstructured":"Frommer, L. & Kahaly, G. J. Type 1 diabetes and associated autoimmune diseases. World J. Diabetes 11, 527\u2013539 (2020).","journal-title":"World J. Diabetes"},{"key":"1226_CR21","unstructured":"National Institute for Health and Care Excellence. When should I screen for hypothyroidism? NICE https:\/\/cks.nice.org.uk\/topics\/hypothyroidism\/diagnosis\/screening\/ (2024)."},{"key":"1226_CR22","doi-asserted-by":"publisher","first-page":"988","DOI":"10.4158\/EP12280.GL","volume":"18","author":"JR Garber","year":"2012","unstructured":"Garber, J. R. et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr. Pract. 18, 988\u20131028 (2012).","journal-title":"Endocr. Pract."},{"key":"1226_CR23","doi-asserted-by":"publisher","first-page":"E1274","DOI":"10.1503\/cmaj.190395","volume":"191","author":"R Birtwhistle","year":"2019","unstructured":"Birtwhistle, R. et al. Recommendation on screening adults for asymptomatic thyroid dysfunction in primary care. CMAJ 191, E1274\u2013E1280 (2019).","journal-title":"CMAJ"},{"key":"1226_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1515797","volume":"13","author":"X Huang","year":"2025","unstructured":"Huang, X., Wu, Y., Ni, Y. & He, Y. Global, regional, and national burden of type 2 diabetes mellitus caused by high BMI from 1990 to 2021, and forecast to 2045: analysis from the Global Burden of Disease Study 2021. Front. Public. Health 13, 1515797 (2025).","journal-title":"Front. Public. Health"},{"key":"1226_CR25","doi-asserted-by":"publisher","DOI":"10.2174\/0115733998274323231230131843","volume":"21","author":"WC Guzman-Vilca","year":"2024","unstructured":"Guzman-Vilca, W. C. & Carrillo-Larco, R. M. Number of people with type 2 diabetes mellitus in 2035 and 2050: a modelling study in 188 countries. Curr. Diabetes Rev. 21, e120124225603 (2024).","journal-title":"Curr. Diabetes Rev."},{"key":"1226_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-019-0463-3","volume":"20","author":"I Kyrou","year":"2020","unstructured":"Kyrou, I. et al. Sociodemographic and lifestyle-related risk factors for identifying vulnerable groups for type 2 diabetes: a narrative review with emphasis on data from Europe. BMC Endocr. Disord. 20, 134 (2020).","journal-title":"BMC Endocr. Disord."},{"key":"1226_CR27","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1210\/jc.2015-3235","volume":"101","author":"HF Fleiner","year":"2016","unstructured":"Fleiner, H. F. et al. Prevalence of thyroid dysfunction in autoimmune and type 2 diabetes: the population-based HUNT study in Norway. J. Clin. Endocrinol. Metab. 101, 669\u2013677 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1226_CR28","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1089\/met.2015.0045","volume":"13","author":"IM Bense\u00f1or","year":"2015","unstructured":"Bense\u00f1or, I. M. et al. Thyrotropin levels, insulin resistance, and metabolic syndrome: a cross-sectional analysis in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Metab. Syndr. Relat. Disord. 13, 362\u2013369 (2015).","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"1226_CR29","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1210\/jc.2006-1718","volume":"92","author":"A Roos","year":"2007","unstructured":"Roos, A. et al. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J. Clin. Endocrinol. Metab. 92, 491\u2013496 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1226_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1089\/thy.2016.0171","volume":"27","author":"JE Jun","year":"2017","unstructured":"Jun, J. E. et al. Association between changes in thyroid hormones and incident type 2 diabetes: a seven-year longitudinal study. Thyroid 27, 29\u201338 (2017).","journal-title":"Thyroid"},{"key":"1226_CR31","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1530\/EJE-22-0523","volume":"187","author":"H Alwan","year":"2022","unstructured":"Alwan, H. et al. Subclinical thyroid dysfunction and incident diabetes: a systematic review and an individual participant data analysis of prospective cohort studies. Eur. J. Endocrinol. 187, S35\u2013S46 (2022).","journal-title":"Eur. J. Endocrinol."},{"key":"1226_CR32","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1007\/s40618-023-02079-3","volume":"46","author":"S Pinto","year":"2023","unstructured":"Pinto, S., Croce, L., Carlier, L., Cosson, E. & Rotondi, M. Thyroid dysfunction during gestation and gestational diabetes mellitus: a complex relationship. J. Endocrinol. Invest. 46, 1737\u20131759 (2023).","journal-title":"J. Endocrinol. Invest."},{"key":"1226_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1614802","volume":"16","author":"S Pinto","year":"2025","unstructured":"Pinto, S. et al. Association between hypothyroidism and metabolic profile in gestational diabetes mellitus. Front. Endocrinol. 16, 1614802 (2025).","journal-title":"Front. Endocrinol."},{"key":"1226_CR34","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4093\/dmj.2022.0013","volume":"46","author":"YS Eom","year":"2022","unstructured":"Eom, Y. S., Wilson, J. R. & Bernet, V. J. Links between thyroid disorders and glucose homeostasis. Diabetes Metab. J. 46, 239\u2013256 (2022).","journal-title":"Diabetes Metab. J."},{"key":"1226_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0215372","volume":"14","author":"K Giannakou","year":"2019","unstructured":"Giannakou, K. et al. Risk factors for gestational diabetes: an umbrella review of meta-analyses of observational studies. PLoS ONE 14, e0215372 (2019).","journal-title":"PLoS ONE"},{"key":"1226_CR36","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S2213-8587(25)00068-3","volume":"13","author":"JAJ Osinga","year":"2025","unstructured":"Osinga, J. A. J. et al. Association of gestational thyroid function and thyroid autoimmunity with gestational diabetes: a systematic review and individual participant meta-analysis. Lancet Diabetes Endocrinol. 13, 651\u2013661 (2025).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1226_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1555409","volume":"16","author":"C Zou","year":"2025","unstructured":"Zou, C., Shen, Q., Yang, Y., Liao, Y. & Du, Q. Association of maternal thyroid function and gestational diabetes with pregnancy outcomes: a retrospective cohort study. Front. Endocrinol. 16, 1555409 (2025).","journal-title":"Front. Endocrinol."},{"key":"1226_CR38","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1089\/thy.2016.0457","volume":"27","author":"EK Alexander","year":"2017","unstructured":"Alexander, E. K. et al. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid 27, 315\u2013389 (2017).","journal-title":"Thyroid"},{"key":"1226_CR39","doi-asserted-by":"publisher","first-page":"e261","DOI":"10.1097\/AOG.0000000000003893","volume":"135","author":"[No authors listed]","year":"2020","unstructured":"[No authors listed] Thyroid disease in pregnancy: ACOG Practice Bulletin, number 223. Obstet. Gynecol. 135, e261\u2013e274 (2020).","journal-title":"Obstet. Gynecol."},{"key":"1226_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2019.101320","volume":"34","author":"A Stagnaro-Green","year":"2020","unstructured":"Stagnaro-Green, A., Dong, A. & Stephenson, M. D. Universal screening for thyroid disease during pregnancy should be performed. Best. Pract. Res. Clin. Endocrinol. Metab. 34, 101320 (2020).","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"1226_CR41","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1136\/jech.2003.008466","volume":"58","author":"M Delgado-Rodr\u00edguez","year":"2004","unstructured":"Delgado-Rodr\u00edguez, M. & Llorca, J. Bias. J. Epidemiol. Community Health 58, 635\u2013641 (2004).","journal-title":"J. Epidemiol. Community Health"},{"key":"1226_CR42","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1464-5491.1995.tb00553.x","volume":"12","author":"P Perros","year":"1995","unstructured":"Perros, P., McCrimmon, R. J., Shaw, G. & Frier, B. M. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet. Med. 12, 622\u2013627 (1995).","journal-title":"Diabet. Med."},{"key":"1226_CR43","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1210\/jc.2003-032089","volume":"89","author":"RW Flynn","year":"2004","unstructured":"Flynn, R. W. et al. The thyroid epidemiology, audit, and research study: thyroid dysfunction in the general population. J. Clin. Endocrinol. Metab. 89, 3879\u20133884 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1226_CR44","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1210\/clinem\/dgad371","volume":"108","author":"N Plei\u0107","year":"2023","unstructured":"Plei\u0107, N., Gunja\u010da, I., Babi\u0107 Leko, M. & Zemunik, T. Thyroid function and metabolic syndrome: a two-sample bidirectional Mendelian randomization study. J. Clin. Endocrinol. Metab. 108, 3190\u20133200 (2023).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1226_CR45","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S2213-8587(18)30371-1","volume":"7","author":"J Jonklaas","year":"2019","unstructured":"Jonklaas, J. & Razvi, S. Reference intervals in the diagnosis of thyroid dysfunction: treating patients not numbers. Lancet Diabetes Endocrinol. 7, 473\u2013483 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1226_CR46","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1007\/s11695-017-2965-2","volume":"27","author":"B Guan","year":"2017","unstructured":"Guan, B. et al. Effect of bariatric surgery on thyroid function in obese patients: a systematic review and meta-analysis. Obes. Surg. 27, 3292\u20133305 (2017).","journal-title":"Obes. Surg."},{"key":"1226_CR47","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1530\/EJE-13-0339","volume":"169","author":"MA Lips","year":"2013","unstructured":"Lips, M. A. et al. Roux-en-Y gastric bypass and calorie restriction induce comparable time-dependent effects on thyroid hormone function tests in obese female subjects. Eur. J. Endocrinol. 169, 339\u2013347 (2013).","journal-title":"Eur. J. Endocrinol."},{"key":"1226_CR48","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.soard.2021.02.028","volume":"17","author":"C Azran","year":"2021","unstructured":"Azran, C. et al. Hypothyroidism and levothyroxine therapy following bariatric surgery: a systematic review, meta-analysis, network meta-analysis, and meta-regression. Surg. Obes. Relat. Dis. 17, 1206\u20131217 (2021).","journal-title":"Surg. Obes. Relat. Dis."},{"key":"1226_CR49","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/cen.14901","volume":"99","author":"SA Tee","year":"2023","unstructured":"Tee, S. A., Tsatlidis, V. & Razvi, S. The GLP-1 receptor agonist exenatide reduces serum TSH by its effect on body weight in people with type 2 diabetes. Clin. Endocrinol. 99, 401\u2013408 (2023).","journal-title":"Clin. Endocrinol."},{"key":"1226_CR50","doi-asserted-by":"publisher","first-page":"R137","DOI":"10.1530\/EJE-14-0067","volume":"171","author":"F Santini","year":"2014","unstructured":"Santini, F. et al. Mechanisms in endocrinology: the crosstalk between thyroid gland and adipose tissue: signal integration in health and disease. Eur. J. Endocrinol. 171, R137\u2013R152 (2014).","journal-title":"Eur. J. Endocrinol."},{"key":"1226_CR51","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1055\/s-0042-121421","volume":"48","author":"LC Fontenelle","year":"2016","unstructured":"Fontenelle, L. C. et al. Thyroid function in human obesity: underlying mechanisms. Horm. Metab. Res. 48, 787\u2013794 (2016).","journal-title":"Horm. Metab. Res."},{"key":"1226_CR52","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/ijo.2009.140","volume":"33","author":"M Nannipieri","year":"2009","unstructured":"Nannipieri, M. et al. Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and\/or type 2 diabetes: effects of weight loss. Int. J. Obes. 33, 1001\u20131006 (2009).","journal-title":"Int. J. Obes."},{"key":"1226_CR53","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.2147\/DMSO.S277486","volume":"13","author":"X Chen","year":"2020","unstructured":"Chen, X., Zhang, C., Liu, W., Zhang, J. & Zhou, Z. Laparoscopic sleeve gastrectomy-induced decreases in FT3 and TSH are related to fasting C-peptide in euthyrioid patients with obesity. Diabetes. Metab. Syndr. Obes. 13, 4077\u20134084 (2020).","journal-title":"Diabetes. Metab. Syndr. Obes."},{"key":"1226_CR54","doi-asserted-by":"publisher","first-page":"e4251","DOI":"10.1210\/clinem\/dgab183","volume":"106","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. Causal association between serum thyrotropin and obesity: a bidirectional, Mendelian randomization study. J. Clin. Endocrinol. Metab. 106, e4251\u2013e4259 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1226_CR55","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.2018.13770","volume":"320","author":"M Feller","year":"2018","unstructured":"Feller, M. et al. Association of thyroid hormone therapy with quality of life and thyroid-related symptoms in patients with subclinical hypothyroidism: a systematic review and meta-analysis. JAMA 320, 1349\u20131359 (2018).","journal-title":"JAMA"},{"key":"1226_CR56","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/cen.12824","volume":"84","author":"O Okosieme","year":"2016","unstructured":"Okosieme, O. et al. Management of primary hypothyroidism: statement by the British Thyroid Association executive committee. Clin. Endocrinol. 84, 799\u2013808 (2016).","journal-title":"Clin. Endocrinol."},{"key":"1226_CR57","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1089\/thy.2018.0251","volume":"29","author":"S Razvi","year":"2019","unstructured":"Razvi, S., Korevaar, T. I. M. & Taylor, P. Trends, determinants, and associations of treated hypothyroidism in the United Kingdom, 2005\u20132014. Thyroid 29, 174\u2013182 (2019).","journal-title":"Thyroid"},{"key":"1226_CR58","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s12020-016-1095-2","volume":"55","author":"F Song","year":"2017","unstructured":"Song, F. et al. The prevalence and determinants of hypothyroidism in hospitalized patients with type 2 diabetes mellitus. Endocrine 55, 179\u2013185 (2017).","journal-title":"Endocrine"},{"key":"1226_CR59","doi-asserted-by":"publisher","first-page":"e208","DOI":"10.3399\/bjgp20X708065","volume":"70","author":"D McCahon","year":"2020","unstructured":"McCahon, D., Haque, M. S., Parle, J., Hobbs, F. R. & Roberts, L. M. Subclinical thyroid dysfunction symptoms in older adults: cross-sectional study in UK primary care. Br. J. Gen. Pract. 70, e208\u2013e214 (2020).","journal-title":"Br. J. Gen. Pract."},{"key":"1226_CR60","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","volume":"87","author":"JG Hollowell","year":"2002","unstructured":"Hollowell, J. G. et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 87, 489\u2013499 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1226_CR61","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1530\/EJE-21-1172","volume":"186","author":"U Javaid","year":"2022","unstructured":"Javaid, U., Kennedy, D., Addison, C., Tsatlidis, V. & Razvi, S. Frequency, determinants and costs of thyroid function testing in a laboratory serving a large population. Eur. J. Endocrinol. 186, 553\u2013560 (2022).","journal-title":"Eur. J. Endocrinol."},{"key":"1226_CR62","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1210\/jc.2007-1499","volume":"92","author":"MI Surks","year":"2007","unstructured":"Surks, M. I. & Hollowell, J. G. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 92, 4575\u20134582 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1226_CR63","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1089\/thy.2017.0715","volume":"28","author":"X Zhai","year":"2018","unstructured":"Zhai, X. et al. An age-specific serum thyrotropin reference range for the diagnosis of thyroid diseases in older adults: a cross-sectional survey in China. Thyroid 28, 1571\u20131579 (2018).","journal-title":"Thyroid"},{"key":"1226_CR64","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1001\/jama.2023.19052","volume":"330","author":"SY Lee","year":"2023","unstructured":"Lee, S. Y. & Pearce, E. N. Hyperthyroidism: a review. JAMA 330, 1472\u20131483 (2023).","journal-title":"JAMA"},{"key":"1226_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135233","volume":"10","author":"C Han","year":"2015","unstructured":"Han, C. et al. Subclinical hypothyroidism and type 2 diabetes: a systematic review and meta-analysis. PLoS ONE 10, e0135233 (2015).","journal-title":"PLoS ONE"},{"key":"1226_CR66","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1089\/thy.2019.0572","volume":"30","author":"A Bano","year":"2020","unstructured":"Bano, A. et al. Thyroid function and the risk of fibrosis of the liver, heart, and lung in humans: a systematic review and meta-analysis. Thyroid 30, 806\u2013820 (2020).","journal-title":"Thyroid"},{"key":"1226_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00700","volume":"9","author":"X Ding","year":"2018","unstructured":"Ding, X. et al. Subclinical hypothyroidism in polycystic ovary syndrome: a systematic review and meta-analysis. Front. Endocrinol. 9, 700 (2018).","journal-title":"Front. Endocrinol."},{"key":"1226_CR68","first-page":"147","volume":"4","author":"S Vyakaranam","year":"2014","unstructured":"Vyakaranam, S., Vanaparthy, S., Nori, S., Palarapu, S. & Bhongir, A. V. Study of insulin resistance in subclinical hypothyroidism. Int. J. Health Sci. Res. 4, 147\u2013153 (2014).","journal-title":"Int. J. Health Sci. Res."},{"key":"1226_CR69","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1677\/JME-09-0107","volume":"44","author":"C Lu","year":"2010","unstructured":"Lu, C. & Cheng, S. Y. Thyroid hormone receptors regulate adipogenesis and carcinogenesis via crosstalk signaling with peroxisome proliferator-activated receptors. J. Mol. Endocrinol. 44, 143\u2013154 (2010).","journal-title":"J. Mol. Endocrinol."},{"key":"1226_CR70","first-page":"1","volume":"58","author":"KA Moskva","year":"2015","unstructured":"Moskva, K. A. et al. Effect of pioglitazone on thyroid stimulating hormone and insulin resistance in hypothyroid patients [abstract 976]. Diabetologia 58, 1\u2013607 (2015).","journal-title":"Diabetologia"},{"key":"1226_CR71","doi-asserted-by":"publisher","first-page":"E143","DOI":"10.1210\/jc.2013-2965","volume":"99","author":"R Lupoli","year":"2014","unstructured":"Lupoli, R. et al. Effects of treatment with metformin on TSH levels: a meta-analysis of literature studies. J. Clin. Endocrinol. Metab. 99, E143\u2013E148 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1226_CR72","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1530\/EJE-21-0634","volume":"185","author":"HJ Kim","year":"2021","unstructured":"Kim, H. J. et al. Thyroid autoimmunity and metabolic syndrome: a nationwide population-based study. Eur. J. Endocrinol. 185, 707\u2013715 (2021).","journal-title":"Eur. J. Endocrinol."},{"key":"1226_CR73","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1086\/519978","volume":"45","author":"CJ Hoffmann","year":"2007","unstructured":"Hoffmann, C. J. & Brown, T. T. Thyroid function abnormalities in HIV-infected patients. Clin. Infect. Dis. 45, 488\u2013494 (2007).","journal-title":"Clin. Infect. Dis."},{"key":"1226_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2020.113356","volume":"293","author":"SB Melamed","year":"2020","unstructured":"Melamed, S. B. et al. Thyroid function assessment before and after diagnosis of schizophrenia: a community-based study. Psychiatry Res. 293, 113356 (2020).","journal-title":"Psychiatry Res."},{"key":"1226_CR75","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1210\/jc.2016-1726","volume":"101","author":"VV Shanbhogue","year":"2016","unstructured":"Shanbhogue, V. V., Finkelstein, J. S., Bouxsein, M. L. & Yu, E. W. Association between insulin resistance and bone structure in nondiabetic postmenopausal women. J. Clin. Endocrinol. Metab. 101, 3114\u20133122 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1226_CR76","doi-asserted-by":"publisher","first-page":"R21","DOI":"10.1530\/JOE-21-0364","volume":"253","author":"HI Jansen","year":"2022","unstructured":"Jansen, H. I., Bruinstroop, E., Heijboer, A. C. & Boelen, A. Biomarkers indicating tissue thyroid hormone status: ready to be implemented yet? J. Endocrinol. 253, R21\u2013R45 (2022).","journal-title":"J. Endocrinol."},{"key":"1226_CR77","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1530\/EJE-10-0538","volume":"163","author":"NH Birkebaek","year":"2010","unstructured":"Birkebaek, N. H. et al. Effect of weight reduction on insulin sensitivity, sex hormone-binding globulin, sex hormones and gonadotrophins in obese children. Eur. J. Endocrinol. 163, 895\u2013900 (2010).","journal-title":"Eur. J. Endocrinol."},{"key":"1226_CR78","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1530\/EC-18-0499","volume":"7","author":"C Krause","year":"2018","unstructured":"Krause, C. et al. Reduced expression of thyroid hormone receptor \u03b2 in human nonalcoholic steatohepatitis. Endocr. Connect. 7, 1448\u20131456 (2018).","journal-title":"Endocr. Connect."},{"key":"1226_CR79","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1016\/S0140-6736(19)32517-6","volume":"394","author":"SA Harrison","year":"2019","unstructured":"Harrison, S. A. et al. Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet 394, 2012\u20132024 (2019).","journal-title":"Lancet"},{"key":"1226_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00451","volume":"10","author":"P de Candia","year":"2019","unstructured":"de Candia, P. et al. Type 2 diabetes: how much of an autoimmune disease? Front. Endocrinol. 10, 451 (2019).","journal-title":"Front. Endocrinol."},{"key":"1226_CR81","doi-asserted-by":"publisher","first-page":"908","DOI":"10.2337\/dc12-0931","volume":"36","author":"MI Hawa","year":"2013","unstructured":"Hawa, M. I. et al. Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7. Diabetes Care 36, 908\u2013913 (2013).","journal-title":"Diabetes Care"},{"key":"1226_CR82","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1210\/er.2009-0002","volume":"30","author":"E Diamanti-Kandarakis","year":"2009","unstructured":"Diamanti-Kandarakis, E. et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr. Rev. 30, 293\u2013342 (2009).","journal-title":"Endocr. Rev."},{"key":"1226_CR83","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1210\/er.2015-1010","volume":"36","author":"AC Gore","year":"2015","unstructured":"Gore, A. C. et al. EDC-2: The Endocrine Society\u2019s second scientific statement on endocrine-disrupting chemicals. Endocr. Rev. 36, E1\u2013E150 (2015).","journal-title":"Endocr. Rev."},{"key":"1226_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00513","volume":"9","author":"SG Howard","year":"2018","unstructured":"Howard, S. G. Developmental exposure to endocrine disrupting chemicals and type 1 diabetes mellitus. Front. Endocrinol. 9, 513 (2018).","journal-title":"Front. Endocrinol."},{"key":"1226_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18122583","volume":"18","author":"V Calsolaro","year":"2017","unstructured":"Calsolaro, V., Pasqualetti, G., Niccolai, F., Caraccio, N. & Monzani, F. Thyroid disrupting chemicals. Int. J. Mol. Sci. 18, 2583 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"1226_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054537","volume":"24","author":"C Hinault","year":"2023","unstructured":"Hinault, C., Caroli-Bosc, P., Bost, F. & Chevalier, N. Critical overview on endocrine disruptors in diabetes mellitus. Int. J. Mol. Sci. 24, 4537 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1226_CR87","doi-asserted-by":"publisher","first-page":"E488","DOI":"10.1152\/ajpendo.00068.2023","volume":"324","author":"J Martinez-Pinna","year":"2023","unstructured":"Martinez-Pinna, J. et al. Endocrine disruptors in plastics alter \u03b2-cell physiology and increase the risk of diabetes mellitus. Am. J. Physiol. Endocrinol. Metab. 324, E488\u2013E505 (2023).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1226_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2021.101562","volume":"35","author":"J Kohrle","year":"2021","unstructured":"Kohrle, J. & Fradrich, C. Thyroid hormone system disrupting chemicals. Best. Pract. Res. Clin. Endocrinol. Metab. 35, 101562 (2021).","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"1226_CR89","first-page":"14","volume":"121","author":"F Goulart-Silva","year":"2013","unstructured":"Goulart-Silva, F., Serrano-Nascimento, C., Texeira, S. S. & Nunes, M. T. Triiodothyronine (T3) induces proinsulin gene expression by activating PI3K: possible roles for GSK-3\u03b2 and the transcriptional factor PDX-1. Exp. Clin. Endocrinol. Diabetes. 121, 14\u201319 (2013).","journal-title":"Exp. Clin. Endocrinol. Diabetes."},{"key":"1226_CR90","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1038\/oby.2009.110","volume":"17","author":"FJ Ortega","year":"2009","unstructured":"Ortega, F. J. et al. Subcutaneous fat shows higher thyroid hormone receptor-\u03b11 gene expression than omental fat. Obesity 17, 2134\u20132141 (2009).","journal-title":"Obesity"},{"key":"1226_CR91","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/390534","volume":"2013","author":"C Wang","year":"2013","unstructured":"Wang, C. The relationship between type 2 diabetes mellitus and related thyroid diseases. J. Diabetes Res. 2013, 390534 (2013).","journal-title":"J. Diabetes Res."},{"key":"1226_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2011.05.009","volume":"342","author":"JM Weitzel","year":"2011","unstructured":"Weitzel, J. M. & Iwen, K. A. Coordination of mitochondrial biogenesis by thyroid hormone. Mol. Cell Endocrinol. 342, 1\u20137 (2011).","journal-title":"Mol. Cell Endocrinol."},{"key":"1226_CR93","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1097\/HEP.0000000000000551","volume":"81","author":"L Marino","year":"2025","unstructured":"Marino, L., Kim, A., Ni, B. & Celi, F. S. Thyroid hormone action and liver disease, a complex interplay. Hepatology 81, 651\u2013669 (2025).","journal-title":"Hepatology"},{"key":"1226_CR94","doi-asserted-by":"publisher","first-page":"17416","DOI":"10.3748\/wjg.v20.i46.17416","volume":"20","author":"LA Videla","year":"2014","unstructured":"Videla, L. A. et al. T3-induced liver AMP-activated protein kinase signaling: redox dependency and upregulation of downstream targets. World. J. Gastoenterol. 20, 17416\u201317425 (2014).","journal-title":"World. J. Gastoenterol."},{"key":"1226_CR95","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1677\/jme.1.02166","volume":"38","author":"CV Falzacappa","year":"2007","unstructured":"Falzacappa, C. V. et al. Thyroid hormone receptor TR\u03b21 mediates Akt activation by T3 in pancreatic \u03b2 cells. J. Mol. Endocrinol. 38, 221\u2013233 (2007).","journal-title":"J. Mol. Endocrinol."},{"key":"1226_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2014.00082","volume":"5","author":"B Morte","year":"2014","unstructured":"Morte, B. & Bernal, J. Thyroid hormone action: astrocyte-neuron communication. Front. Endocrinol. 5, 82 (2014).","journal-title":"Front. Endocrinol."},{"key":"1226_CR97","doi-asserted-by":"publisher","first-page":"E510","DOI":"10.1210\/jc.2011-1754","volume":"97","author":"G Chen","year":"2012","unstructured":"Chen, G., Xu, S., Renko, K. & Derwahi, M. Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents. J. Clin. Endocrinol. Metab. 97, E510\u2013E520 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1226_CR98","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-025-01943-y","volume":"25","author":"S Liu","year":"2025","unstructured":"Liu, S. et al. Circulating leptin levels in thyroid dysfunction: a systematic review and meta-analysis. BMC Endocr. Disord. 25, 140 (2025).","journal-title":"BMC Endocr. Disord."},{"key":"1226_CR99","first-page":"339","volume":"62","author":"IS Markos","year":"2023","unstructured":"Markos, I. S. et al. The concentration of interleukin 6 and tumor necrosis factor alpha in saliva and blood of patients with inactive multiple sclerosis and coexisting Hashimoto\u2019s thyroiditis. Acta Clin. Croat. 62, 339\u2013344 (2023).","journal-title":"Acta Clin. Croat."},{"key":"1226_CR100","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.mehy.2006.12.056","volume":"69","author":"E Tjorve","year":"2007","unstructured":"Tjorve, E., Tjorve, K. M. C., Olsen, J. O., Senum, R. & Oftebro, H. On commonness and rarity of thyroid hormone resistance: a discussion based on mechanisms of reduced sensitivity in peripheral tissues. Med. Hypotheses. 69, 913\u2013921 (2007).","journal-title":"Med. Hypotheses."},{"key":"1226_CR101","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2337\/dc18-1410","volume":"42","author":"M Lacraustra","year":"2019","unstructured":"Lacraustra, M. et al. Impaired sensitivity to thyroid hormones is associated with diabetes and metabolic syndrome. Diabetes Care 42, 303\u2013310 (2019).","journal-title":"Diabetes Care"},{"key":"1226_CR102","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1089\/thy.2021.0500","volume":"32","author":"Y Sun","year":"2022","unstructured":"Sun, Y. et al. Impaired sensitivity to thyroid hormones is associated with hyperuricemia, obesity, and cardiovascular disease risk in subjects with subclinical hypothyroidism. Thyroid 32, 376\u2013384 (2022).","journal-title":"Thyroid"},{"key":"1226_CR103","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s40618-024-02463-7","volume":"48","author":"C Zhang","year":"2025","unstructured":"Zhang, C. et al. Effects of acarbose and metformin on thyroid function and thyroid hormone sensitivity in type 2 diabetes patients: a post-hoc analysis of the MARCH study. J. Endocrinol. Invest. 48, 419\u2013433 (2025).","journal-title":"J. Endocrinol. Invest."},{"key":"1226_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2025.103780","volume":"24","author":"L Sessa","year":"2025","unstructured":"Sessa, L., Malavolta, E., Sodero, G., Cipolla, C. & Rigante, D. The conspiring role of gut microbiota as primer of autoimmune thyroid diseases: a scoping focus. Autoimm. Rev. 24, 103780 (2025).","journal-title":"Autoimm. Rev."},{"key":"1226_CR105","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41574-019-0156-z","volume":"15","author":"EE Canfora","year":"2019","unstructured":"Canfora, E. E., Meex, R. C. R., Venema, K. & Blaak, E. E. Gut microbial metabolites in obesity, NAFLD and T2DM. Nat. Rev. Endocrinol. 15, 261\u2013273 (2019).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1226_CR106","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1114424","volume":"14","author":"J Wu","year":"2023","unstructured":"Wu, J., Yang, K., Fan, H., Wei, M. & Xiong, Q. Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus. Front. Endocrinol. 14, 1114424 (2023).","journal-title":"Front. Endocrinol."},{"key":"1226_CR107","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1661211","volume":"16","author":"T Jiang","year":"2025","unstructured":"Jiang, T. et al. Gut microbiota in hypothyroidism: pathogenic mechanisms and opportunities for precision microbiome interventions. Front. Microbiol. 16, 1661211 (2025).","journal-title":"Front. Microbiol."},{"key":"1226_CR108","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0296733","volume":"19","author":"Q Shu","year":"2024","unstructured":"Shu, Q. et al. Effect of probiotics or prebiotics on thyroid function: a meta-analysis of eight randomized controlled trials. PLoS ONE 19, e0296733 (2024).","journal-title":"PLoS ONE"},{"key":"1226_CR109","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1365-2265.1983.tb00018.x","volume":"19","author":"RS Gray","year":"1983","unstructured":"Gray, R. S., Borsey, D. Q., Irvine, W. J., Seth, J. & Clarke, B. F. Natural history of thyroid function in diabetics with impaired thyroid reserve: a four year controlled study. Clin. Endocrinol. 19, 445\u2013451 (1983).","journal-title":"Clin. Endocrinol."},{"key":"1226_CR110","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.2174\/1381612825666190918162649","volume":"25","author":"J Wang","year":"2019","unstructured":"Wang, J., Gao, J., Fan, Q., Li, H. & Di, Y. The effect of metformin on thyroid-associated serum hormone levels and physiological indexes: a meta-analysis. Curr. Pharm. Des. 25, 3257\u20133265 (2019).","journal-title":"Curr. Pharm. Des."},{"key":"1226_CR111","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1159\/000501895","volume":"8","author":"ME Sencar","year":"2019","unstructured":"Sencar, M. E. et al. The effect of exenatide on thyroid-stimulating hormone and thyroid volume. Eur. Thyroid. J. 8, 307\u2013311 (2019).","journal-title":"Eur. Thyroid. J."},{"key":"1226_CR112","first-page":"275","volume":"16","author":"D K\u00f6seo\u011flu","year":"2020","unstructured":"K\u00f6seo\u011flu, D., \u00d6zdemir Ba\u015fer, \u00d6, Berker, D. & G\u00fcler, S. Exenatide treatment reduces thyroid gland volume, but has no effect on the size of thyroid nodules. Acta Endocrinol. 16, 275\u2013279 (2020).","journal-title":"Acta Endocrinol."},{"key":"1226_CR113","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1786559","volume":"2022","author":"J Ye","year":"2022","unstructured":"Ye, J., Xu, J., Wen, W. & Huang, B. Effect of liraglutide on serum TSH levels in patients with NAFLD and its underlying mechanisms. Int. J. Clin. Pract. 2022, 1786559 (2022).","journal-title":"Int. J. Clin. Pract."},{"key":"1226_CR114","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.2169\/internalmedicine.8830-21","volume":"61","author":"T Hitsuwari","year":"2022","unstructured":"Hitsuwari, T. et al. Two cases of thyrotoxicosis and euglycemic diabetic ketoacidosis under sodium-glucose transport protein 2 inhibitor treatment. Intern. Med. 61, 3069\u20133075 (2022).","journal-title":"Intern. Med."},{"key":"1226_CR115","first-page":"182","volume":"38","author":"EA Nikkila","year":"1960","unstructured":"Nikkila, E. A. & Teir, H. Effects of long-term use of antidiabetic sulfonylureas on thyroid weight and arteriosclerosis. Ann. Med. Exp. Biol. Fenn. 38, 182\u2013185 (1960).","journal-title":"Ann. Med. Exp. Biol. Fenn."},{"key":"1226_CR116","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2415-7-8","volume":"7","author":"S Lee","year":"2007","unstructured":"Lee, S., Tsirbas, A., Goldberg, R. A. & McCann, J. D. Thiazolidinedione induced thyroid associated orbitopathy. BMC Ophthalmol. 7, 8 (2007).","journal-title":"BMC Ophthalmol."},{"key":"1226_CR117","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1172\/JCI60047","volume":"122","author":"GA Brent","year":"2012","unstructured":"Brent, G. A. Mechanisms of thyroid hormone action. J. Clin. Invest. 122, 3035\u20133043 (2012).","journal-title":"J. Clin. Invest."},{"key":"1226_CR118","doi-asserted-by":"publisher","first-page":"E513","DOI":"10.1152\/ajpendo.00659.2007","volume":"294","author":"LP Klieverik","year":"2008","unstructured":"Klieverik, L. P. et al. Effects of thyrotoxicosis and selective hepatic autonomic denervation on hepatic glucose metabolism in rats. Am. J. Physiol. Endocrinol. Metab. 294, E513\u2013E520 (2008).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1226_CR119","doi-asserted-by":"publisher","first-page":"178","DOI":"10.2337\/diab.35.2.178","volume":"35","author":"JP Randin","year":"1986","unstructured":"Randin, J. P., Tappy, L., Scazziga, B., Jequier, E. & Felber, J. P. Insulin sensitivity and exogenous insulin clearance in Graves\u2019 disease. Measurement by the glucose clamp technique and continuous indirect calorimetry. Diabetes 35, 178\u2013181 (1986).","journal-title":"Diabetes"},{"key":"1226_CR120","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1210\/jcem-70-4-1167","volume":"70","author":"MC Foss","year":"1990","unstructured":"Foss, M. C. et al. Peripheral glucose metabolism in human hyperthyroidism. J. Clin. Endocrinol. Metab. 70, 1167\u20131172 (1990).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1226_CR121","first-page":"641","volume":"13","author":"B Havekes","year":"2010","unstructured":"Havekes, B. & Sauerwein, H. P. Adipocyte-myocyte crosstalk in skeletal muscle insulin resistance; is there a role for thyroid hormone. Curr. Opin. Clin. Nutr. Metab. Care 13, 641\u2013646 (2010).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"1226_CR122","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMra042972","volume":"352","author":"DS Cooper","year":"2005","unstructured":"Cooper, D. S. Antithyroid drugs. N. Engl. J. Med. 352, 905\u2013917 (2005).","journal-title":"N. Engl. J. Med."},{"key":"1226_CR123","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/nrendo.2013.193","volume":"9","author":"L Bartalena","year":"2013","unstructured":"Bartalena, L. Diagnosis and management of Graves\u2019 disease: a global overview. Nat. Rev. Endocrinol. 9, 724\u2013734 (2013).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1226_CR124","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000043328","volume":"104","author":"L Tan","year":"2025","unstructured":"Tan, L. et al. NOACs versus warfarin in people with atrial fibrillation and thyroid dysfunction. Medicine 104, e43328 (2025).","journal-title":"Medicine"},{"key":"1226_CR125","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1089\/thy.2014.0028","volume":"24","author":"J Jonklaas","year":"2014","unstructured":"Jonklaas, J. et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on thyroid hormone replacement. Thyroid 24, 1670\u20131751 (2014).","journal-title":"Thyroid"},{"key":"1226_CR126","doi-asserted-by":"publisher","first-page":"4930","DOI":"10.1210\/jc.2006-0478","volume":"91","author":"G Dimitriadis","year":"2006","unstructured":"Dimitriadis, G. et al. Insulin action in adipose tissue and muscle in hypothyroidism. J. Clin. Endocrinol. Metab. 91, 4930\u20134937 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1226_CR127","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1046\/j.1464-5491.2002.00635.x","volume":"19","author":"A Mohn","year":"2002","unstructured":"Mohn, A., Di Michele, S., Di Luzio, R., Tumini, S. & Chiarelli, F. The effect of subclinical hypothyroidism on metabolic control in children and adolescents with type 1 diabetes mellitus. Diabet. Med. 19, 70\u201373 (2002).","journal-title":"Diabet. Med."},{"key":"1226_CR128","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-023-06516-7","volume":"16","author":"A Ostadrahimi","year":"2023","unstructured":"Ostadrahimi, A. et al. Effects of levothyroxine replacement therapy on insulin resistance in patients with untreated primary hypothyroidism. BMC Res. Notes 16, 237 (2023).","journal-title":"BMC Res. Notes"},{"key":"1226_CR129","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/S0140-6736(11)60276-6","volume":"379","author":"DS Cooper","year":"2012","unstructured":"Cooper, D. S. & Biondi, B. Subclinical thyroid disease. Lancet 379, 1142\u20131154 (2012).","journal-title":"Lancet"},{"key":"1226_CR130","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1001\/jama.2010.1361","volume":"304","author":"N Rodondi","year":"2010","unstructured":"Rodondi, N. et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 304, 1365\u20131374 (2010).","journal-title":"JAMA"},{"key":"1226_CR131","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1001\/archinternmed.2012.402","volume":"172","author":"TH Collet","year":"2012","unstructured":"Collet, T. H. et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch. Intern. Med. 172, 799\u2013809 (2012).","journal-title":"Arch. Intern. Med."},{"key":"1226_CR132","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000356507","volume":"2","author":"SH Pearce","year":"2013","unstructured":"Pearce, S. H. et al. 2013 ETA guideline: management of subclinical hypothyroidism. Eur. Thyroid. J. 2, 215\u2013228 (2013).","journal-title":"Eur. Thyroid. J."},{"key":"1226_CR133","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000438750","volume":"4","author":"B Biondi","year":"2015","unstructured":"Biondi, B. et al. The 2015 European Thyroid Association guidelines on diagnosis and treatment of endogenous subclinical hyperthyroidism. Eur. Thyroid. J. 4, 149\u2013163 (2015).","journal-title":"Eur. Thyroid. J."},{"key":"1226_CR134","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.674841","volume":"12","author":"LE Zijlstra","year":"2021","unstructured":"Zijlstra, L. E. et al. Levothyroxine treatment and cardiovascular outcomes in older people with subclinical hypothyroidism: pooled individual results of two randomised controlled trials. Front. Endocrinol. 12, 674841 (2021).","journal-title":"Front. Endocrinol."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-025-01226-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-025-01226-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-025-01226-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T01:01:40Z","timestamp":1773709300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-025-01226-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":134,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1226"],"URL":"https:\/\/doi.org\/10.1038\/s41574-025-01226-5","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"10 December 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}